KRW
MEDP icon

Kaufman Rossin Wealth’s Medpace MEDP Stock Holding History

Kaufman Rossin Wealth’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Sell
524
-57
-10% -$26.3K 0.13% 79
2026
Q1 		$279K Sell
581
-214
-27% -$110K 0.16% 75
2025
Q4 		$447K Buy
795
+26
+3% +$14.8K 0.23% 66
2025
Q3 		$395K Buy
+769
New +$336K 0.22% 66

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Kaufman Rossin Wealth's MEDP Position: Q2 2026 in Review

Kaufman Rossin Wealth reduced its Medpace (MEDP) stake by 9.8% in Q2 2026, selling an estimated $26.3K and leaving 524 shares worth $281K. The position accounts for 0.13% of the portfolio, ranked #79.

Kaufman Rossin Wealth first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $447K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Kaufman Rossin Wealth held 524 shares of Medpace worth $281K as of Q2 2026.
  • Kaufman Rossin Wealth sold 57 Medpace shares in Q2 2026, an estimated $26.3K.
  • Medpace made up 0.13% of Kaufman Rossin Wealth's portfolio in Q2 2026, its #79 holding.
  • Kaufman Rossin Wealth first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Kaufman Rossin Wealth's Medpace position peaked at $447K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Kaufman Rossin Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.